MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-23-2026
Avidity Biosciences P/CF Ratio 2011-2026 | RNA
Annual P/CF Ratio Avidity Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -15.4 | -10.9 | -9.27 | -9.18 | -7.41 | -14.1 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -7.41 | -15.4 | -11 |
P/CF Ratio of other stocks in the Biotechnology industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Apellis Pharmaceuticals
APLS
|
61.2 | $ 20.15 | -2.68 % | $ 2.54 B |  USA |
 |
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M |  Germany |
 |
Aptorum Group Limited
APM
|
-3.44 | $ 0.82 | -3.48 % | $ 4.47 M |  China |
 |
Axsome Therapeutics
AXSM
|
-92.9 | $ 163.7 | -1.61 % | $ 8.14 B | USA |
 |
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M | China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M |  France |
 |
AbCellera Biologics
ABCL
|
-7.33 | $ 3.72 | -2.75 % | $ 1.11 B |  Canada |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Burford Capital Limited
BUR
|
11.6 | $ 8.52 | -2.46 % | $ 1.39 B | Britain |
 |
Corvus Pharmaceuticals
CRVS
|
-3.93 | $ 17.75 | -0.79 % | $ 852 M | USA |
 |
Adverum Biotechnologies
ADVM
|
-0.826 | - | - | $ 86.2 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - |  Russia |
 |
Certara
CERT
|
11.2 | $ 7.16 | 1.49 % | $ 1.15 B | USA |
 |
ARCA biopharma
ABIO
|
-8.36 | - | 1052.0 % | $ 415 M | USA |
 |
Acer Therapeutics
ACER
|
-0.401 | - | 2.71 % | $ 14 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-6.14 | - | - | $ 2.17 B | USA |
 |
Acorda Therapeutics
ACOR
|
-1.2 | - | -24.86 % | $ 820 K | USA |
 |
Capricor Therapeutics
CAPR
|
-6.07 | $ 25.91 | -3.56 % | $ 694 M | USA |
 |
Acasti Pharma
ACST
|
-2.73 | - | 4.01 % | $ 150 M | Canada |
 |
Codexis
CDXS
|
-5.9 | $ 0.99 | -3.28 % | $ 72.7 M | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
14.6 | $ 24.0 | 0.5 % | $ 2.93 B | USA |
 |
CureVac N.V.
CVAC
|
-4.82 | - | - | $ 867 M | Germany |
 |
Aeterna Zentaris
AEZS
|
-4.82 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-0.64 | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
-1.3 | - | 1.93 % | $ 17.4 M | USA |
 |
Agenus
AGEN
|
-0.000958 | $ 3.19 | -4.64 % | $ 1.14 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
-0.224 | - | - | $ 7.46 M |  Israel |
 |
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | USA |
 |
Agios Pharmaceuticals
AGIO
|
-4.37 | $ 28.78 | -1.44 % | $ 1.67 B | USA |
 |
Champions Oncology
CSBR
|
14.3 | $ 6.0 | -1.15 % | $ 82 M | USA |
 |
Advaxis
ADXS
|
-0.0633 | - | -9.65 % | $ 45.9 M | USA |
 |
Akouos
AKUS
|
-2.7 | - | 0.23 % | $ 488 M | USA |
 |
Завод ДИОД
DIOD
|
7.49 | - | - | - | Russia |
 |
Фармсинтез
LIFE
|
-8.26 | - | - | - | Russia |
 |
Albireo Pharma
ALBO
|
-5 | - | -0.23 % | $ 916 M | USA |
 |
Cellectis S.A.
CLLS
|
-1.94 | $ 3.67 | -3.42 % | $ 116 M | France |
 |
Alector
ALEC
|
-1.34 | $ 2.11 | -4.75 % | $ 217 M | USA |
 |
KalVista Pharmaceuticals
KALV
|
-5.04 | $ 15.68 | -2.4 % | $ 779 M | Britain |
 |
Allena Pharmaceuticals
ALNA
|
-2.48 | - | 3.16 % | $ 1.9 M | USA |
 |
Aileron Therapeutics
ALRN
|
-1.71 | - | 10.36 % | $ 9.8 M | USA |
 |
Altimmune
ALT
|
-5.8 | $ 4.17 | 0.24 % | $ 296 M | USA |
 |
Teligent, Inc.
TLGT
|
-0.3 | - | -13.85 % | $ 16.1 M | USA |
 |
AlloVir
ALVR
|
-0.723 | - | 4.14 % | $ 49.1 M | USA |
 |
Viela Bio, Inc.
VIE
|
-3.37 | - | - | $ 2.91 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-0.0776 | - | -11.43 % | $ 502 K | USA |
 |
Amarin Corporation plc
AMRN
|
862 | $ 14.27 | 2.44 % | $ 5.92 B |  Irlanda |